The breviscapus is mainly distributed in the southwestern part of China, especially in Yunnan. Breviscapine is an active ingredient of flavonoids extracted from Erigeron breviscapus, and its main active ingredient is scutellarin. Breviscapine has the effects of increasing blood flow, improving microcirculation, dilating blood vessels, lowering blood viscosity, etc. It has been widely used in the treatment of cerebral infarction, ischemic heart disease, dizziness, senile dementia and nephrotic syndrome.